Characterization of Allograft Rejection in an Experimental Model of Small Intestinal Transplantation

Journal of Gastrointestinal Surgery

Volumn 2, Issue 4, 1998, Pages 325-332

  Hayashi, Michihiro ^a   Martinez, Olivia M ^a   Krams, Sheri M ^a   Burns, Washington ^b   Esquivel, Carlos O ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ALLOTRANSPLANTATION; ANIMAL; APOPTOSIS; ARTICLE; AUGUST COPENHAGEN IRISH RAT; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; HETEROTOPIC TRANSPLANTATION; IMMUNOLOGY; INTESTINE MUCOSA; ISOGRAFT; LEWIS RAT; MALE; PATHOLOGY; RAT; SMALL INTESTINE; TRANSPLANTATION;

ACUTE DISEASE; ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-6; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; RATS; RATS, INBRED ACI; RATS, INBRED LEW; RNA, MESSENGER; TACROLIMUS; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032106999     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(98)80071-1     Document Type: Article

References (23)

1. Todo S, Tzakis A, Abu-Elmagd K, Reyes J, Starzl TE. Current status of intestinal transplantation. Adv Surg 1994;27:295-317.
2. Todo S, Reyes J, Furukawa H, Abu-Elmagd K, Lee RG, Tzakis A, Rao AS, Starzl TE. Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995;222:270-282.
3. Asfar S, Wood R, Grant DR. Clinical diagnosis in intestinal allograft rejection, in Solez K, Racusen LC, Billingham ME, eds. Solid Organ Transplantation Rejection. New York: Marcel Dekker, 1996.
4. Lee RG, Nakamura K, Tsamandas AC, Abu-Elmagd K, Furukawa H, Hutson WR, Reyes J, Tabasco-Minguillan JS, Todo S, Demetris AJ. Pathology of human intestinal transplantation. Gastroenterology 1996;110:1820-1834.
5. McDiarmid SV, Farmer DH, Kuniyoshi JS, Robert M, Khadavi A, Shaked A, Busuttil RW. The correlation of intragraft cytokine expression with rejection in rat small intestine transplantation. Transplantation 1994;58:690-697.
6. Toogood GJ, Rankin AM, Tam PKH, Morris PJ, Dallman MJ. The immune response following small bowel transplantation. I. An unusual pattern of cytokine expression. Transplantation 1996;62:851-855.
7. Monchik GJ, Russell PS. Transplantation of small bowel in the rat. Technical and immunological considerations. Surgery 1971;70:693-702.
8. Garcia B, Zhong R, Wijsman P, Chen PWH, Sutherland F, Duff J, Grant D. Pathological changes following intestinal transplantation in the rat. Transplant Proc 1990;22:2469-2470.
9. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
10. Krams SM, Falco DA, Villanueva JC, Rabkin J, Tomlanovich SJ, Vincenti F, Amend WJC, Melzer J, Garovoy MR, Roberts JP, Ascher NL, Martinez OM. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992;53:151-156.
11. Egawa H, Martinez, OM, Quinn MB, Villanueva JC, So S, Esquivel CO, Krams SM. Acute liver allograft rejection in the rat. An analysis of the immune response. Transplantation 1995;59:97-102.
12. Grant D, Zhong R, Gunn H, Duff J, Garcia B, Keown P, Wijsman J, Stiller C. Graft-versus-host disease associated with intestinal transplantation in the rat: Host immune function and general histology. Transplantation 1989;48:545-549.
13. Banner BF. Pathology of intestinal transplantation. In Solez K, Racusen LC, Billingham ME, eds. Solid Organ Transplantation Rejection. New York: Marcel Dekker, 1996.
14. Su GL, Walgenbach K-J, Heeckt PH, Wang Q, Halfter W, Whiteside TL, Bauer AJ. Increased expression of interferon-γ in a rat model of chronic intestinal allograft rejection. Transplantation 1996;62:242-248.
15. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP), lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996;157:1261-1270.
16. Halloran P, Goes N. Interferon-γ and its receptor. Transplant Sci 1993;3:92-103,
17. Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989;83:724-727.
18. Sartor RB. Cytokines in intestinal inflammation: Pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-539.
19. Liesenfield O, Kosek J, Remington JS, Suzuki Y. Association of CD4+ T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med 1996;184: 597-607.
20. Quan D, Grant DR, Zhong RZ, Zhang Z, Garcia BM, Jevnikar AM. Altered gene expression of cytokine, ICAM-1, and class II molecules precedes mouse intestinal allograft rejection. Transplantation 1994;58:808-816.
21. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990;81:301-305.
22. Mitsuyama K, Sasaki E, Toyonaga A, Ikeda H, Tsuruta O, Irie A, Arima N, Oriishi T, Harada K, Fujisaki K, Sato M, Tanikawa K. Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 1991;50:104-111.
23. Noguchi K, Yoshida Y, Yagihashi A, Kita Y, Takenaka T, Terasawa K, Hayashi S, Konno A, Kobayashi M, Nakamura K, Reyes J, Abu-Elmagd K, Demetris AJ, Tzakis AG, Todo S, Iwaki Y, Starzl TE. Serum levels of interleukin-6, tumor necrosis factor-α, and interleukin-2 in rejecting human small bowel allografts. Transplant Proc 1992;24:1152.